Hoechst Pakistan Limited (KASE: HPL)
Health Care · Pharmaceuticals · PK
PKRs4,002.97
+0.45% today · +6.2% 1Y
Hoechst Pakistan Limited (KASE: HPL) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $139.19M.
Over the last twelve months the share price has gained 6.2%, trading between 3.60K and 4.89K.
Tweenvest scores Hoechst Pakistan Limited across four factors: quality 73/100, value 44/100, dividend 89/100. Its strongest factor is dividend.
HPL price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $139.19M
- Revenue (TTM)
- $112.83M
- P/E
- 10.30
- EPS
- 388.64
- Dividend yield
- 6.00%
- Beta (5Y)
- 0.24
- 52-week high
- PKRs4,889.99
- 52-week low
- PKRs3,602.00
- Avg volume (3M)
- —
- Shares outstanding
- 9.64M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.06T | $1,189.41 | -3.59% |
| Johnson & JohnsonNYSE: JNJ | $650.67B | $270.00 | -1.15% |
| Merck & Co., Inc.NYSE: MRK | $377.72B | $153.10 | -2.14% |
| Roche Holding AGSWX: ROP | $365.10B | CHF368.30 | -1.47% |
| Novartis AGSWX: NOVN | $300.07B | CHF127.18 | -0.90% |
| AstraZeneca PLCLSE: AZN | $257.89B | £122.34 | -1.94% |
| Novo Nordisk A/SCPSE: NOVO B | $210.23B | Dkr304.95 | -0.93% |
| Pfizer Inc.NYSE: PFE | $161.30B | $28.30 | -0.95% |
Figures last refreshed Aug 18, 2026.